In an 87-year-old patient with pneumonia who has a paronychia not responding to Augmentin (amoxicillin‑clavulanate), what additional treatment should be prescribed?

Treatment Recommendation for Augmentin-Resistant Paronychia

Switch to an anti-staphylococcal agent targeting methicillin-sensitive Staphylococcus aureus (MSSA), such as cephalexin 500mg four times daily or dicloxacillin 500mg four times daily, combined with incision and drainage if an abscess is present.

Rationale and Clinical Approach

Primary Pathogen and Treatment Failure

Paronychia that fails to respond to Augmentin is most commonly caused by Staphylococcus aureus, which accounts for approximately 30% of isolated bacteria in paronychia cases 1. While Augmentin typically covers most paronychia pathogens with only 4.7% resistance rates 1, treatment failure suggests either:

• Inadequate drainage of a localized abscess
• MSSA requiring more targeted anti-staphylococcal coverage
• Less commonly, MRSA (particularly in healthcare-exposed or immunocompromised patients)

Immediate Management Steps

1. Assess for Abscess Formation

• Examine for fluctuance, pointing, or visible purulent collection
• If abscess present: Drainage is mandatory 2, 3. Simple warm soaks are insufficient once an abscess has formed
• Drainage options range from needle decompression to formal incision with a scalpel, depending on abscess size and location 2

2. Antibiotic Selection For an 87-year-old with treatment failure on Augmentin:

• First-line empiric switch: Cephalexin 500mg QID or dicloxacillin 500mg QID for 7-10 days
• These provide superior anti-staphylococcal activity compared to Augmentin
• Consider MRSA coverage (trimethoprim-sulfamethoxazole DS twice daily or doxycycline 100mg twice daily) if:
  • Patient has healthcare exposure
  • Recent hospitalization for pneumonia increases MRSA risk
  • No improvement after 48-72 hours on MSSA-directed therapy
  • Local MRSA prevalence is high

3. Culture Guidance

• Obtain bacterial culture if drainage is performed 1
• In complicated cases or immunocompromised patients (relevant given age and concurrent pneumonia), bacteriological sampling helps guide therapy 1
• For simple paronychia, systematic sampling has limited clinical benefit 1

Critical Considerations for This Patient

Age and Comorbidity Factors:

• At 87 years with concurrent pneumonia, this patient may have:
  • Compromised immune function
  • Potential for polymicrobial infection 4
  • Higher risk for treatment complications

Avoid Common Pitfalls:

• Do not continue Augmentin if no improvement after 48-72 hours
• Do not rely on antibiotics alone if an abscess is present—drainage is essential 2, 3
• Do not use oral antibiotics as monotherapy without adequate drainage when fluctuance is present 2
• Preoperative antibiotics are generally unnecessary and should be avoided 1

Duration and Follow-up

• Postoperative antibiotics: 7-10 days is typically sufficient
• Recent evidence shows postoperative antibiotics may not influence recurrence in uncomplicated paronychia 1, but given this patient's age and treatment failure, a full course is prudent
• Recurrence rate is low (3.9%) with appropriate management 1
• Re-evaluate in 48-72 hours; if no improvement, consider MRSA coverage or alternative diagnosis

When to Escalate

Refer for surgical consultation if:

• Extensive soft tissue involvement
• Signs of deep space infection (flexor tenosynovitis)
• Failure to respond to drainage and appropriate antibiotics within 48-72 hours
• Concern for osteomyelitis in chronic cases

The combination of adequate surgical drainage (if indicated) plus targeted anti-staphylococcal antibiotics addresses the most likely cause of Augmentin failure in this elderly patient 1, 2, 5.